Redmile Group LLC 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Redmile Group LLC | 0 0.000% |
-63,436 (Position Closed) |
Filing |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Redmile Group LLC | 63,436 5.990% |
-50,000 (-44.08%) |
Filing |